Leprosy is a paradigm of the complex disturbances of cell-mediated immunity (CMI) that may be associated with chronic infection by obligate intracellular microorganisms. Patients with lepromatous leprosy are anergic to the antigens of Mycobacterium leprae as demonstrated by skin test and by the poor blastogenic response of their lymphocytes to M. leprae in vitro (9, 26) . In addition, many of these patients manifest a generalized, nonspecific impairmnent of CMI (6) .
Few would question the role of the host immune response as a major determinant in the clinical course of this very chronic infection. In fact, it is widely believed that some of the human population may be genetically deficient in their capacity to mount an effective cell-mediated immune response to specific antigenic determinants of M. leprae (4) . Such individuals would, in effect, be "predestined" to develop lepromatous leprosy upon infection with this pathogen. As yet, however, there is no strong evidence that this hypothesis is correct, based on studies of leprosy in monozygotic twins (40) or from analysis of multifactorial genetic traits and HLA phenotype frequencies among patients (5, 29, 31 ).
An important question equally worth investigating is the effect of microbial factors upon the mechanisms of CMI once a nidus of mycobacterial infection has been established. An excellent model for such study is experimental murine leprosy that is caused by the obligate intracellular pathogen Mycobacterium lepraemurium.
Intravenous inoculation of rats and mice with this organism gives rise to a chronic granulomatous infection that preferentially invades the lymphoid organs. The histopathology of lymph nodes is similar to that observed in human lepromatous leprosy. There is extensive invasion of the paracortical areas by pale-staining histiocytes that contain masses of acid-fast-staining bacilli. Malphighian corpuscles of the splenic white pulp are heavily infiltrated by histiocytes that appear to displace lymphocytes from the periarteriolar lymphocyte sheaths (7) .
In this communication we report the results of several studies performed to determine the impact of a chronic infection with M. lepraemurium upon the cell-mediated immune response of inbred Lewis rats as compared with littermate controls. Preliminary studies demonstrated that peak delayed-type hypersensitivity responses to primary sensitization with SRBC occurred on day 9 or 10 in normal Lewis rats. Therefore, on day 9 after sensitization, infected and control rats were challenged by injecting 0.1 ml of a 7.5% SRBC suspension into the footpad of one hind paw. Swelling was measured 24 h later by the mercury-displacement paw-volume method of Axelrad (3). Paw-volume differences on repeated readings did not differ by more than ±2% of the volume; differences of 0.02 ml could be detected. The degree of swelling was expressed as the percent increase in paw volume over the volume measured immediately prior to SRBC challenge. The responses of control groups of normal and infected rats given only the challenge dose of SRBC were also measured. At 3 days after SRBC challenge, normal and infected animals were bled for the assay of hemagglutinating antibody. Sera were heated at 56°C for 30 min and serially diluted in physiological saline containing 10% pooled normal Lewis rat serum determined to be free of SRBC hemagglutinating activity. The 10% concentration of normal serum was employed throughout to stabilize the hemagglutination reaction. Doubled dilutions of test sera, starting at 1:10, were made in microtiter plates. All titrations were performed in duplicate by using appropriate positive and negative controls. To 100 pl of a serum dilution, 50 ,ll of 0.25% SRBC was added. Plates were held at room temperature for 2 h and then refrigerated at 4°C overnight. The titer was recorded as the last dilution showing 1+ or more SRBC agglutination.
MATERIALS AND METHODS

Animals
Statistical methods. Unless otherwise stated, the Mann-Whitney test for two independent samples was employed to determine the significance of differences among groups (11) . RESULTS AD. At 40 days after i.p. inoculation with 5 x 10' viable M. lepraemurium, infected rats and littermate controls were injected in the left hind footpad with M. tuberculosis in Bayol F (3 mg/ml) to induce AD. Body weights of control and infected rats were equal, and the latter were normal by clinical examination at the time of footpad injection. During the period of 12 to 24 days after adjuvant injection, eight of nine control rats manifested AD of 3+ severity by the criteria described above. Severity in the ninth control animal was 2+. Conversely, the severity of AD was markedly reduced in infected rats. Two of nine developed no AD whatever, and a maximum score of 1+ was recorded for each of the remaining seven animals. The experiment was repeated, this time with a larger group of leprous rats that had been infected with M. lepraemurium 175 days previously. Again, all 21 controls developed AD, and in 17 (81%) the disease was of maximum (3+) severity (Table  1 ). In the 20 leprous rats, however, all manifestations of AD were abolished.
To ascertain whether a second injection of adjuvant could "override" the blocking effect of infection, AD in control rats was allowed to diminish to a minimumn level of activity. Then, 58 days after the first adjuvant, a second injection was given into the right hind footpad of nine rats in each group. There was recrudescence of AD in all nine of the reinjected controls (Table 1) . However, AD was less severe after the second injection, and no illness of 3+ severity was observed. In the nine infected rats a second injection of adjuvant did induce AD, but it was even milder than among controls. The severity score in seven out of nine rats did not exceed 0 to 1+.
An additional observation of interest is shown in Fig. 1 . Among control rats, the latency period before the onset of clinical AD after the first injection of adjuvant was significantly shortened from a median of 17 days (range, 13 to 24 days) to 11 days (range, 7 to 16 days) after the second injection (P < 0.001). Conversely, the latency period in infected rats after a second adjuvant injection was 18 days (range, 11 to 23 days). Thus, in addition to preventing AD after one injection of adjuvant, M. lepraemurium infection also blocked the accelerated onset of AD that was observed among control rats after a second injection of adjuvant.
To determine whether inoculation with viable M. lepraemurium was a prerequisite for the blockade of AD, two groups of rats were injected i.p. with 8 x 109 viable or heat-killed organisms and challenged with adjuvant 60 days later. As shown in Table 2 (group C), AD in controls was severe, whereas it was absent or miniimal in recipients of viable M. lepraemurium. AD in recipients of heat-killed M. lepraemurium was less severe than in the control group, but of greater severity than in rats that had been injected with viable organisms. To permit a statistical evaluation by chi-square analysis, the severity scores of rats in groups B and C were combined into two sets defined as minimal AD (0 to 1+) or severe disease (2+ to 3+). The difference in severity of AD between groups B and C was highly significant (P < 0.001).
The sera of infected rats contain antibodies to antigens of M. lepraemurium that cross-react with antigens of M. tuberculosis (23 groups of normal rats were infused daily with serum from normal or infected donors during the first 9 days after adjuvant injection; each rat received a total serum dosage of 9 ml i.v. There was no difference in the severity of AD between the two groups of serum recipients, and in both the severity was slightly reduced ( Table  2 , groups D and E). These results also militate against the presence of nonspecific immunosuppressive factors in serum that were responsible for attenuation of AD in infected rats. A few xenogenic cells from the infected pelvic fat pads of CF mice may have survived the procedures of homogenization and inoculation into rats. Therefore, these cells might have induced a cell-mediated immune response that could attenuate the AD in infected rats. However, this possibility was excluded by the demonstration that i.p. inoculation of normal rats with normal mouse fat pads equivalent in weight to infected fat pads did not alter the severity of AD after adjuvant injection 60 days later ( Table  2 , group F).
To control for the possibility that rats chronically infected with M. lepraemurium might have been superinfected by other microorganisms that could have altered the host response to adjuvant, nine leprous rats infected for more than 175 days were sacrificed, and numerous samples from organs and blood were cultured for the presence of aerobic and anaerobic organisms and for cultivatable Mycobacteria. All cultures were negative, and extensive histopathological examination yielded no evidence for respiratory disease or tumor.
Finally, as a check on the capacity of infected rats to mount a nonspecific inflammatory response, the reaction to subcutaneous turpentine injection (0.1 ml) was measured in six pairs of normal and infected rats, respectively. The mean diameter of the inflammatory response at 24 h did not differ between the groups, and no differ- (Table 4) . Clinical manifestations were extremely severe, and the histopathology was characterized by severe perivascular inflammation throughout the CNS composed predominantly of neutrophils and smaller numbers of mononuclear cells. Many inflamed vessels were surrounded by areas of edema and hemorrhage. Frequently, vascular lumens were occluded by thrombi. In infected rats, hyperacute EAE was somewhat delayed in onset (median, 11 days), and the severity as judged by the composite of clinical and histological scores was significantly reduced (P < 0.05). The inflammatory reactions of CNS in leprous rats were less numerous and of smaller size than those observed among controls. Furthermore, thrombosis and perivascular hemorrhage were present in only one animal.
Survival of skin homografts. The capacity of infected Lewis rats (AgB') to reject homografts from donors differing at the major histocompatibility locus was assessed by placement of full-thickness skin grafts from BN rats (AgB3). Littermate controls were also grafted. The median survival time of BN homografts on 14 normal Lewis rats was 8 days, with a range of 7 to 9 days (Fig. 2) . On infected rats the median graft survival time was 10 days, with a range of 8 to 14 days; 8 of 15 leprous rats maintained their grafts for 10 days or longer. The difference in graft survival time between normal and infected rats was highly significant (P c 0.001).
Delayed-type hypersensitivity and antibodies to SRBC. At 60 days after the onset of infection, 12 leprous and control rats, respectively, were sensitized to SRBC by the intradermal route. After 9 days, they were challenged by the injection of 0.1 ml of 7.5% SRBC into the opposite paw. The median percent increase in paw volume at 24 h after the challenge of control rats was 8.9 (range, 2.4 to 23.2%), whereas paw volume increased only 4.5% (range, 0.0 to 9.1%) among the infected rats. The difference was significant (P < 0.02). At 3 days after the challenge dose of SRBC, rats were bled for the determination of hemagglutinating antibody titers. The median antibody titer to SRBC in both infected and normal controls was 1:40, with a range of 1:80 to 1:160. DISCUSSION The present studies have demonstrated that chronic infection of Lewis rats with M. lepraemurium either blocks or markedly inhibits the pathogenesis of two experimental autoimmune diseases, AD and EAE, that are mediated by thymus-dependent lymphocytes (19, 27, 38, 39) . Other T-cell-mediated responses, namely, skin homograft rejection and the delayed-type hypersensitivity response to SRBC (3, 14) , also were impaired significantly in leprous rats. The fact that these T-cell responses were expressed fully in littermate control rats demonstrates conclusively that the impairment of cell-mediated immune function in leprous rats was a consequence of the infection itself.
The suppressor effect of infection did not ap- (18, 37) . In addition, Jankovic (21) has observed that in guinea pigs sensitized with Freund adjuvant and reinjected with adjuvant plus India ink, carbon particles were present in regional lymph nodes at 6 h after the injection. Second, the extensive recirculation of immunocompetent lymphocytes that occurs in mammals virtually assures the arrival of T-lymphocytes in large numbers at local sites of granulomatous inflammation. These cells appear to enter areas of chronic inflammation by passing through newly formed capillaries with high endothelium (34) . Likewise, T-cells almost certainly gain rapid access to antigenic material in the proximal lymph nodes of leprous rats since it has been demonstrated that there is an equal rate of entry of radiolabeled T-cells into normal lymph nodes and into nodes extensively damaged by granuloma formation (8) .
Preinjection of animals with thymus-dependent antigens can diminish AD, EAE, and other T-cell-mediated immune responses fpr varying lengths of time (13, 20, 24) . This inhibition of immune responses to one antigen by prior administration of another or even the same antigen has traditionally been described as "antigenic competition." Of interest is the fact that antigenic competition is particularly intense if
Freund complete adjuvant is employed as the sensitizing antigenic stimulus (2) . Preliminary infornation as to why this may be so has been provided by recent studies suggesting that thymus-dependent lymphocytes are modulators of antigenic competition (17) and by the demonstration that Freund adjuvant exerts a regulatory effect on T-cell function (30) . Adjuvant injection of mice induces the proliferation of both helper and suppressor T-cells. The latter population has been shown to severely depress the generation of cytotoxic T-cell activity in vitro (30) . We have observed that infection of mice with M. lepraemurium induces the proliferation of potent suppressor cell populations that nonspecifically depress thymus-dependent immune responses in vitro and in vivo (W. E. Bullock and E. M. Carlson, submitted for publication). It is not known precisely how these suppressor cells are generated. However, it is known that the pathology of murine leprosy is characterized by extensive histiocytic cell invasion of the paracortical region of lymph nodes and the periarteriolar lymphocyte sheaths of the splenic white pulp (7) . Furthermore, these pathological changes are associated with a marked perturbation in the traffic of recirculating T-cells that normally migrate through the paracortical areas of lymph nodes and splenic white pulp. This disturbance is caused by massive, nonspecific trapping of recirculating T-cells within these organs and possibly also by the liver (8) . Such extensive trapping ofrecirculating cells may thus impair cell-mediated immune responses to a variety of antigens by reducing the number of immunocompetent cells available to react with antigenic stimuli at other sites.
Of greater potential significance is the possibility that the entrapment of immunocompetent lymphocytes within the lymphoid organs of infected animals exposes the cells to a microenvironment in which their function in the amplification of the immune response is actually subverted to another, namely, suppressor function. Potent suppressor cell activity is also induced in experimental animals by injection of Corynebacterium parvum or infection with BCG (16, 32) . Both procedures cause changes within lymphoid organs that are associated with extensive trapping of lymphocytes (15, 41) . Thus, the common elements of pathology within lymphoid organs that interfere with cell migration in the presence of persistent antigens may also be significant determinants in the generation of suppressor cell activity. immunodeficiency of the cell-mediated type has been reported in experimental infections with Plasmodia (22) , trypanosomes (1), and Protozoa (35) . In humans, reversible, nonspecific impairment of CMI has been observed in lepromatous leprosy, miliary tuberculosis, and syphilis (6, 25, 36) . The pathology within lymphoid organs differs somewhat among these experimental and human intracellular infections. However, in each, there are similar disturbances of the lymphoid microenvironment by aggregates of the pathogen, macrophages, and lymphocytes in varying proportions. Future studies on the functions of individual host cell types from these aggregates offer great promise in expanding our knowledge of both helper and suppressor immuno-regulatory mechanisms in chronic infectious diseases.
